UPS is buying delivery service Roadie having helped it raise $62m while heart disease treatment developer Nectero Medical secured $19.5m in a Boston Scientific-led round.
Month: September 2021
Jam City plays for $350m
The mobile game developer secured $350m from investors including Netmarble and Kabam and has closed the purchase of gaming studio Ludia.
Cars24 drives to $259m
Tencent was among the investors in a round which valued the automotive e-commerce platform developer at $1.75bn.
Papaya Global packs in $250m
Access Industries and Workday Ventures contributed to a series D round which more than tripled the workforce management platform developer’s valuation to $3.7bn.
Exscientia explores Nasdaq IPO
Dundee spinout Exscientia has filed for an offering that would provide exits for SoftBank Vision Fund 2, Novo, BMS, Celgene, Evotec and Pivotal BioVenture Partners.
Agile accumulates $220m in series C round
Softbank, Foxconn and Xiaomi all backed a series C round for the smart robotics technology developer, which is now valued at over $1bn.
Obsidian Therapeutics rocks $115m series B
Amgen, Bristol Myers Briggs and Vertex Pharmaceuticals were among the investors that brought the gene therapy developer’s overall funding to over $164m.
Ximalaya descends from US offering
The Tencent-backed audio streaming platform developer cancelled its plans to float in New York after the Chinese authorities asked it to consider listing in Hong Kong.
Lexeo Therapeutics bags $100m
The gene therapy developer secured backing from Lundbeck and Alexandria Real Estate Equities in a series B round that will support the advancement of its clinical pipeline.
Zeotap taps into series C extension
Liberty Global helped the MathCapital and Here-backed customer intelligence software provider take its series C funding to $71.5m.
Affinity connects to $80m series C round
MassMutual Ventures and Advance Venture Partners returned to back the relationship management tool provider’s latest round, which brought its overall funding to $120m.
Lycia Pharmaceuticals rakes in $70m
Eli Lilly and Alexandria Real Estate Equities are among the investors in a round that took the protein drug developer’s total funding to over $150m.
HomeLane spruces up $50m series E
HomeLane has now taken in over $104m of funding since it was founded, including a series E round backed by Pidilite Group.
Corporates swoop in for Skydweller’s $40m series A
Palantir and Leonardo have helped solar-powered aircraft technology developer Skydweller fill out its oversubscribed series A funding round.